High efficacy of CD19 CAR T cells in patients with transformed Waldenström macroglobulinemia
- PMID: 38669635
- DOI: 10.1182/blood.2024024452
High efficacy of CD19 CAR T cells in patients with transformed Waldenström macroglobulinemia
Abstract
Histologic transformation of Waldenström macroglobulinemia (HT-WM) carries a poor prognosis with standard treatments. Here, we report the first series of HT-WM treated with chimeric antigen receptor T cells showing a high efficacy and no unexpected toxicity.
© 2024 American Society of Hematology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.